306 related articles for article (PubMed ID: 28950820)
1. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
[TBL] [Abstract][Full Text] [Related]
2. How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children's Population.
Trofimiuk M; Wasilewska K; Winnicka K
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261877
[TBL] [Abstract][Full Text] [Related]
3. Extemporaneous drug formulations.
Nahata MC; Allen LV
Clin Ther; 2008 Nov; 30(11):2112-9. PubMed ID: 19108799
[TBL] [Abstract][Full Text] [Related]
4. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
5. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
Giacoia GP; Taylor-Zapata P; Mattison D
Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
[TBL] [Abstract][Full Text] [Related]
6. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
Lam MS
Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
[TBL] [Abstract][Full Text] [Related]
7. Overview of drug product development.
Narayan P
Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
[TBL] [Abstract][Full Text] [Related]
8. Best practices for selection of excipients for paediatrics - Workshop reflection.
Salunke S; Clapham D; Agrawal A; Hughes K; Nunn T
Eur J Pharm Biopharm; 2021 Mar; 160():77-81. PubMed ID: 33400989
[TBL] [Abstract][Full Text] [Related]
9. Paediatric Formulation: Design and Development.
Lopalco A; Denora N
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992469
[TBL] [Abstract][Full Text] [Related]
10. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
11. Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome(.).
Aragao-Santiago L; Bohr A; Delaval M; Dalla-Bona AC; Gessler T; Seeger W; Beck-Broichsitter M
Curr Pharm Des; 2016; 22(9):1147-60. PubMed ID: 26675224
[TBL] [Abstract][Full Text] [Related]
12. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
Rayaprolu BM; Strawser JJ; Anyarambhatla G
Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
[TBL] [Abstract][Full Text] [Related]
13. Challenges in pediatric drug use: A pharmacist point of view.
Balan S; Hassali MA; Mak VSL
Res Social Adm Pharm; 2017; 13(3):653-655. PubMed ID: 27493130
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery and formulations.
Breitkreutz J; Boos J
Handb Exp Pharmacol; 2011; 205():91-107. PubMed ID: 21882107
[TBL] [Abstract][Full Text] [Related]
15. Impact of Porous Excipients on the Manufacturability and Product Performance of Solid Self-Emulsifying Drug Delivery Systems.
Beringhs AO; Minatovicz BC; Zhang GGZ; Chaudhuri B; Lu X
AAPS PharmSciTech; 2018 Oct; 19(7):3298-3310. PubMed ID: 30218264
[TBL] [Abstract][Full Text] [Related]
16. Developing early formulations: practice and perspective.
Li P; Zhao L
Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
[TBL] [Abstract][Full Text] [Related]
17. Applications of various analytical techniques in quality control of pharmaceutical excipients.
Kumar M; Bhatia R; Rawal RK
J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
19. Pediatric drug development: formulation considerations.
Ali AA; Charoo NA; Abdallah DB
Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
[TBL] [Abstract][Full Text] [Related]
20. Application of design space optimization strategy to the development of LC methods for simultaneous analysis of 18 antiretroviral medicines and 4 major excipients used in various pharmaceutical formulations.
Habyalimana V; Mbinze JK; Yemoa AL; Waffo C; Diallo T; Tshilombo NK; Ntokamunda JK; Lebrun P; Hubert P; Marini RD
J Pharm Biomed Anal; 2017 May; 139():8-21. PubMed ID: 28258984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
